Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024

Stock Price vs Company Growth
1d
1.1%
1w
2.4%
1m
0.7%
3m
2.7%
6m
16.2%
all
17.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 896 1.1%
840
940
Company Overview

Sales
2,053 Cr
Growth: 29.3%
Profit after Tax
286 Cr
Growth: 17.3%
Mid Cap
18,851 Cr
P/E: 65.2x
Industry P/E: 33.1x
Fundamentals

Sales (Cr) ₹ 2,053
Growth 29.3%
EBITDA 26.5%
P/S 9.2x
Dividend 0.0%
P/E 65.2x
Book Value ₹ 108
PEG Ratio 2.2x
ROE 15.0%
P/B 8.3x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
Followers (1)